General Practice Doctors in Rochester, NY Accepting Medicare

8 General Practice doctors found. Showing 1 - 8

Dr. Adithya Bala, MD General Practice Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave Bldg 3, Rochester, NY 14621 Phone: 585-922-4000

Dr. Courtney Elizabeth Kodweis, DO General Practice Medicare: Medicare Enrolled Practice Location: 777 Clinton Ave S, Rochester, NY 14620 Phone: 585-279-4800

Dr. Gregory James Zimmer, MD General Practice Medicare: Medicare Enrolled Practice Location: 601 Elmwood Ave, Rochester, NY 14642 Phone: 585-341-3015

Sarah D Atkinson, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 885 Winton Rd S, Finger Lakes Clinical Research, Rochester, NY 14618 Phone: 585-241-9670    Fax: 585-241-3243

Christopher John Davis, M.D., M.P.H., M.B.A General Practice Medicare: Medicare Enrolled Practice Location: 296 Ashbourne Rd, Rochester, NY 14618 Phone: 585-738-9535    Fax: 585-442-8494

Dr. Matthew D Mack, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 340 Arnett Blvd, Rochester, NY 14619 Phone: 585-235-2250    Fax: 585-235-0011

Dr. Kenji Fujitani, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4683    Fax: 585-922-4922

Dr. Jan Andre Grauman Neander, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 57 Westmoreland Dr, Rochester, NY 14620 Phone: 204-619-2411

News Archive

NIH/NIDCR awards $1.1 million grant to Agenta for soft tissue healing development

Agenta Biotechnologies, Inc., a private biotechnology company, announced that it has received a $1.1 million grant from the National Institutes of Health and National Institute of Dental and Craniofacial Research (NIH/NIDCR) for the further development of a biologically activated membrane to improve soft tissue healing associated with oral surgery.

Researchers develop app to encourage and support cognitive creativity by dementia caregivers

Dementia is an ageing-related condition affecting mental acuity and memory. Incidence doubles in a population for every five years over the age of 65 years, so that almost one fifth of those living to 85 can expect to have the condition and a third of those over the age of 95 will likely be affected.

Pimavanserin reduced psychotic symptoms in people with dementia in phase 3 study

A large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in people with dementia, a condition for which no treatments are currently licensed.

Scientists have corrected a flaw in cancer cells that lets them evade the normal cell-death process

Scientists at Dana-Farber Cancer Institute have corrected a flaw in cancer cells that lets them evade the normal cell-death process, and as a result they eliminated leukemia cells from mice.

Read more Medical News

› Verified 7 days ago